cd68 ed1 antibody Search Results


89
Bio-Techne corporation cd68/sr-d1 antibody (ed1) [alexa fluor® 488]
Cd68/Sr D1 Antibody (Ed1) [Alexa Fluor® 488], supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 89/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd68+ed1+antibody/bio-techne+corporation___nb600-985af488?v=Bio-Techne+corporation
Average 89 stars, based on 1 article reviews
cd68/sr-d1 antibody (ed1) [alexa fluor® 488] - by Bioz Stars, 2026-08
89/100 stars
  Buy from Supplier

93
Novus Biologicals cd68
Fig. 4 Givi-MPC decreased inflammation and muscle necrosis in Mdx/SCID mice 7 days after CTX injury. a Representative images of HE and Masson's trichrome staining in Mdx/SCID mice after human myoblasts or control MPC or Givi-MPC transplantation 7 days after CTX injury. Black arrows point at infiltrated inflammatory cells. b, c Quantification of TA muscle fiber necrosis after treatment with MPC 7 days after CTX injury. Human myoblasts: n = 3; control-MPC: n = 4; Givi-MPC: n = 5. d Quantification of <t>CD68-positive</t> cells in TA muscle following MPC transplantation 7 days after CTX injury. n = 4. e Representative images of macrophages (red, <t>CD68)</t> and human cells in TA CTX-injured muscle of Mdx/SCID mice following MPC transplantation. The boxed area is shown below at high magnification. Bar = 100 μm
Cd68, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd68+ed1+antibody/pm33579366-102-45-47?v=Novus+Biologicals
Average 93 stars, based on 1 article reviews
cd68 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

91
Novus Biologicals cd68 sr d1 antibody ed1
Fig. 4 Givi-MPC decreased inflammation and muscle necrosis in Mdx/SCID mice 7 days after CTX injury. a Representative images of HE and Masson's trichrome staining in Mdx/SCID mice after human myoblasts or control MPC or Givi-MPC transplantation 7 days after CTX injury. Black arrows point at infiltrated inflammatory cells. b, c Quantification of TA muscle fiber necrosis after treatment with MPC 7 days after CTX injury. Human myoblasts: n = 3; control-MPC: n = 4; Givi-MPC: n = 5. d Quantification of <t>CD68-positive</t> cells in TA muscle following MPC transplantation 7 days after CTX injury. n = 4. e Representative images of macrophages (red, <t>CD68)</t> and human cells in TA CTX-injured muscle of Mdx/SCID mice following MPC transplantation. The boxed area is shown below at high magnification. Bar = 100 μm
Cd68 Sr D1 Antibody Ed1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd68+ed1+antibody/pmc09812382-324-158-165?v=Novus+Biologicals
Average 91 stars, based on 1 article reviews
cd68 sr d1 antibody ed1 - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

94
Novus Biologicals anti cd68 sr d1
Fig. 4 Givi-MPC decreased inflammation and muscle necrosis in Mdx/SCID mice 7 days after CTX injury. a Representative images of HE and Masson's trichrome staining in Mdx/SCID mice after human myoblasts or control MPC or Givi-MPC transplantation 7 days after CTX injury. Black arrows point at infiltrated inflammatory cells. b, c Quantification of TA muscle fiber necrosis after treatment with MPC 7 days after CTX injury. Human myoblasts: n = 3; control-MPC: n = 4; Givi-MPC: n = 5. d Quantification of <t>CD68-positive</t> cells in TA muscle following MPC transplantation 7 days after CTX injury. n = 4. e Representative images of macrophages (red, <t>CD68)</t> and human cells in TA CTX-injured muscle of Mdx/SCID mice following MPC transplantation. The boxed area is shown below at high magnification. Bar = 100 μm
Anti Cd68 Sr D1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd68+ed1+antibody/10__1097_slash_cm9__0000000000000814-55-32-33?v=Novus+Biologicals
Average 94 stars, based on 1 article reviews
anti cd68 sr d1 - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

90
Novus Biologicals mouse anti ed1 monoclonal
Fig. 4 Givi-MPC decreased inflammation and muscle necrosis in Mdx/SCID mice 7 days after CTX injury. a Representative images of HE and Masson's trichrome staining in Mdx/SCID mice after human myoblasts or control MPC or Givi-MPC transplantation 7 days after CTX injury. Black arrows point at infiltrated inflammatory cells. b, c Quantification of TA muscle fiber necrosis after treatment with MPC 7 days after CTX injury. Human myoblasts: n = 3; control-MPC: n = 4; Givi-MPC: n = 5. d Quantification of <t>CD68-positive</t> cells in TA muscle following MPC transplantation 7 days after CTX injury. n = 4. e Representative images of macrophages (red, <t>CD68)</t> and human cells in TA CTX-injured muscle of Mdx/SCID mice following MPC transplantation. The boxed area is shown below at high magnification. Bar = 100 μm
Mouse Anti Ed1 Monoclonal, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd68+ed1+antibody/pmc02731116-189-46-50?v=Novus+Biologicals
Average 90 stars, based on 1 article reviews
mouse anti ed1 monoclonal - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

92
Novus Biologicals cd68 ed1
Fig. 4 Givi-MPC decreased inflammation and muscle necrosis in Mdx/SCID mice 7 days after CTX injury. a Representative images of HE and Masson's trichrome staining in Mdx/SCID mice after human myoblasts or control MPC or Givi-MPC transplantation 7 days after CTX injury. Black arrows point at infiltrated inflammatory cells. b, c Quantification of TA muscle fiber necrosis after treatment with MPC 7 days after CTX injury. Human myoblasts: n = 3; control-MPC: n = 4; Givi-MPC: n = 5. d Quantification of <t>CD68-positive</t> cells in TA muscle following MPC transplantation 7 days after CTX injury. n = 4. e Representative images of macrophages (red, <t>CD68)</t> and human cells in TA CTX-injured muscle of Mdx/SCID mice following MPC transplantation. The boxed area is shown below at high magnification. Bar = 100 μm
Cd68 Ed1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd68+ed1+antibody/10__1161_slash_hypertensionaha__123__21887-84-41-43?v=Novus+Biologicals
Average 92 stars, based on 1 article reviews
cd68 ed1 - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier

90
Bio-Techne corporation cd68/sr-d1 antibody (ed1) [dylight 405]
Fig. 4 Givi-MPC decreased inflammation and muscle necrosis in Mdx/SCID mice 7 days after CTX injury. a Representative images of HE and Masson's trichrome staining in Mdx/SCID mice after human myoblasts or control MPC or Givi-MPC transplantation 7 days after CTX injury. Black arrows point at infiltrated inflammatory cells. b, c Quantification of TA muscle fiber necrosis after treatment with MPC 7 days after CTX injury. Human myoblasts: n = 3; control-MPC: n = 4; Givi-MPC: n = 5. d Quantification of <t>CD68-positive</t> cells in TA muscle following MPC transplantation 7 days after CTX injury. n = 4. e Representative images of macrophages (red, <t>CD68)</t> and human cells in TA CTX-injured muscle of Mdx/SCID mice following MPC transplantation. The boxed area is shown below at high magnification. Bar = 100 μm
Cd68/Sr D1 Antibody (Ed1) [Dylight 405], supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd68+ed1+antibody/bio-techne+corporation___nb600-985v?v=Bio-Techne+corporation
Average 90 stars, based on 1 article reviews
cd68/sr-d1 antibody (ed1) [dylight 405] - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

N/A
The CD68/SR-D1 Antibody (ED1) [Alexa Fluor® 594] from Novus is a CD68/SR-D1 antibody to CD68/SR-D1. This antibody reacts with Human, Mouse, Rat, Bovine, Feline, Monkey, Primate. The CD68/SR-D1 antibody has been validated for the following
  Buy from Supplier

N/A
The CD68/SR-D1 Antibody (ED1) [Biotin] from Novus is a CD68/SR-D1 antibody to CD68/SR-D1. This antibody reacts with Human, Mouse, Rat, Bovine, Feline, Monkey, Primate. The CD68/SR-D1 antibody has been validated for the following applications: Western
  Buy from Supplier

N/A
The CD68/SR-D1 Antibody (ED1) [DyLight 350] from Novus is a CD68/SR-D1 antibody to CD68/SR-D1. This antibody reacts with Human, Mouse, Rat, Bovine, Feline, Monkey, Primate. The CD68/SR-D1 antibody has been validated for the following applications:
  Buy from Supplier

Image Search Results


Fig. 4 Givi-MPC decreased inflammation and muscle necrosis in Mdx/SCID mice 7 days after CTX injury. a Representative images of HE and Masson's trichrome staining in Mdx/SCID mice after human myoblasts or control MPC or Givi-MPC transplantation 7 days after CTX injury. Black arrows point at infiltrated inflammatory cells. b, c Quantification of TA muscle fiber necrosis after treatment with MPC 7 days after CTX injury. Human myoblasts: n = 3; control-MPC: n = 4; Givi-MPC: n = 5. d Quantification of CD68-positive cells in TA muscle following MPC transplantation 7 days after CTX injury. n = 4. e Representative images of macrophages (red, CD68) and human cells in TA CTX-injured muscle of Mdx/SCID mice following MPC transplantation. The boxed area is shown below at high magnification. Bar = 100 μm

Journal: Stem cell research & therapy

Article Title: Pluripotent stem cell-induced skeletal muscle progenitor cells with givinostat promote myoangiogenesis and restore dystrophin in injured Duchenne dystrophic muscle.

doi: 10.1186/s13287-021-02174-3

Figure Lengend Snippet: Fig. 4 Givi-MPC decreased inflammation and muscle necrosis in Mdx/SCID mice 7 days after CTX injury. a Representative images of HE and Masson's trichrome staining in Mdx/SCID mice after human myoblasts or control MPC or Givi-MPC transplantation 7 days after CTX injury. Black arrows point at infiltrated inflammatory cells. b, c Quantification of TA muscle fiber necrosis after treatment with MPC 7 days after CTX injury. Human myoblasts: n = 3; control-MPC: n = 4; Givi-MPC: n = 5. d Quantification of CD68-positive cells in TA muscle following MPC transplantation 7 days after CTX injury. n = 4. e Representative images of macrophages (red, CD68) and human cells in TA CTX-injured muscle of Mdx/SCID mice following MPC transplantation. The boxed area is shown below at high magnification. Bar = 100 μm

Article Snippet: The muscle sections were incubated with primary antibodies including Laminin (L9393, Sigma, 1:500 and L0663, Sigma, 1:300), dystrophin (D8168, Sigma, 1:200), human-specific dystrophin (NBP2-79783, Novus, 1:200), green fluorescent protein (GFP, #2956, Cell Signal Technologies, 1:500), dystrophin (ab15277, Abcam, 1:200), human nuclear antigen (NBP2-34342, Novus, 1:100), CD68 (NB600-985, Novus, 1:200), CD31 (NB600-562, Novus, 1:200), Pax7 (ab187339, Abcam, 1:300), and human LaminA/C (NBP2-59933, Novus, 1:200) at 4 °C overnight respectively and anti-rabbit/mouse/rat secondary antibodies conjugated to Alexa Fluor 594 or Alexa Fluor 647 or Alexa Fluor 488 (Life Technologies) at room temperature for 1 h. Images were taken using a confocal microscope (FV1000, Olympus, Japan).

Techniques: Staining, Control, Transplantation Assay